Safety of tildrakizumab: a disproportionality analysis based on the FDA adverse event reporting system (FAERS) database from 2018–2023

Overview of attention for article published in Frontiers in Pharmacology, July 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 1 news story.

Credit: Pexels There is a potential signal for new adverse drug reactions (ADRs) among those with psoriatic disease treated…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.